The new laxative lubiprostone improved hyperphosphatemia in hemodialysis patients
نویسندگان
چکیده
منابع مشابه
Adherence and knowledge about hyperphosphatemia treatment in hemodialysis patients with hyperphosphatemia.
INTRODUCTION Adequate dietary phosphorus intake and the use of phosphorus binders are the main tools for treating hyperphosphatemia. Thus, its success depends essentially on the patient's ability to understand and adhere to the dietary plan and the use of phosphate binders. OBJECTIVE To evaluate hyperphosphatemic patients adherence and knowledge about phosphate control treatment. METHODS Th...
متن کاملSevelamer carbonate in the treatment of hyperphosphatemia in patients with chronic kidney disease on hemodialysis
Sevelamer carbonate is an anion exchange pharmaceutical, developed to improve on the performance of the non-absorbable, non-calcium, and metal-free phosphate binder sevelamer hydrochloride. Sevelamer carbonate is expected not to worsen metabolic acidosis, as previously reported during long-term treatment with sevelamer hydrochloride in hemodialysis (HD) patients. Carbonate is the alternate coun...
متن کاملCalcium acetate versus calcium carbonate in the control of hyperphosphatemia in hemodialysis patients.
CONTEXT Hyperphosphatemia has an important role in the development of bone and mineral abnormalities in end-stage renal disease (ESRD). OBJECTIVE To compare the phosphorus binding power and the hypercalcemic effect of calcium acetate and calcium carbonate in hemodialysis patients. TYPE OF STUDY Crossover, randomized, double-blind study. PLACE A private hospital dialysis center. PARTICIP...
متن کاملEducational nursing intervention to reduce the hyperphosphatemia in patients on hemodialysis.
Objective: to evaluate the effectiveness of an educational nursing intervention to reduce hyperphosphataemia in chronic renal patients on hemodialysis. Method: quasi-experimental study with 63 hyperphosphatemic patients on hemodialysis. The intervention consisted of developing and providing a printed and illustrated manual to patients containing information on disease control. The participant...
متن کاملPhosphate salivary secretion in hemodialysis patients: implications for the treatment of hyperphosphatemia.
BACKGROUND/AIMS Hyperphosphatemia is recognized as contributing to the increased risk of cardiac death in end-stage renal disease (ESRD) and hemodialysis (HD) patients. Currently available pharmacologic treatment for hyperphosphatemia is based on phosphate binders but, despite treatment, only half of the patients fall within the range for serum phosphorus of the K/DOQI guidelines. Therefore, th...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Nihon Toseki Igakkai Zasshi
سال: 2018
ISSN: 1340-3451,1883-082X
DOI: 10.4009/jsdt.51.617